BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17510340)

  • 1. Psychiatric research. Putting the brakes on psychosis.
    Schmidt C
    Science; 2007 May; 316(5827):976-7. PubMed ID: 17510340
    [No Abstract]   [Full Text] [Related]  

  • 2. Young people at ultra high risk for psychosis: a research update.
    Yung AR; Nelson B
    Early Interv Psychiatry; 2011 Feb; 5 Suppl 1():52-7. PubMed ID: 21208392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychosis prevention: expectations met].
    Bechdolf A; Peukert R
    Psychiatr Prax; 2011 Feb; 38(2):58-60. PubMed ID: 21394689
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychosis risk syndrome: is it worth the risk?
    Yoon CH; Agius M; Zaman R
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S36-40. PubMed ID: 22945184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioral therapy for individuals at high risk of developing psychosis.
    Addington J; Mancuso E
    J Clin Psychol; 2009 Aug; 65(8):879-90. PubMed ID: 19536867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis.
    French P; Shryane N; Bentall RP; Lewis SW; Morrison AP
    Br J Psychiatry Suppl; 2007 Dec; 51():s82-7. PubMed ID: 18055943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis.
    Cocchi A; Meneghelli A; Preti A
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1003-12. PubMed ID: 19016088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing treatment fidelity in psychotherapy research: novel approach to measure the components of cognitive behavioural therapy for relapse prevention in first-episode psychosis.
    Alvarez-Jimenez M; Wade D; Cotton S; Gee D; Pearce T; Crisp K; McGorry PD; Gleeson JF
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1013-20. PubMed ID: 19016089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention in the at-risk state to prevent transition to psychosis.
    Ruhrmann S; Schultze-Lutter F; Klosterkötter J
    Curr Opin Psychiatry; 2009 Mar; 22(2):177-83. PubMed ID: 19553872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine as a first-choice agent in subjects at high-risk to psychosis?
    O'Connor R; Sota M; Cortesi M; Fusar-Poli P
    Med Hypotheses; 2007; 69(1):230. PubMed ID: 17258403
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of lifetime Axis I morbidity among a treated sample of first-episode psychosis patients.
    Bendall S; Allott K; Johnson T; Jackson HJ; Killackey E; Harrigan S; McGorry PD
    Psychopathology; 2008; 41(2):90-5. PubMed ID: 18033978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.
    Phillips LJ; Nelson B; Yuen HP; Francey SM; Simmons M; Stanford C; Ross M; Kelly D; Baker K; Conus P; Amminger P; Trumpler F; Yun Y; Lim M; McNab C; Yung AR; McGorry PD
    Aust N Z J Psychiatry; 2009 Sep; 43(9):818-29. PubMed ID: 19670055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project.
    Jackson HJ; McGorry PD; Killackey E; Bendall S; Allott K; Dudgeon P; Gleeson J; Johnson T; Harrigan S
    Psychol Med; 2008 May; 38(5):725-35. PubMed ID: 18005494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can antidepressants prevent psychosis?
    Fusar-Poli P; Valmaggia L; McGuire P
    Lancet; 2007 Nov; 370(9601):1746-8. PubMed ID: 18037073
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing the onset of psychosis: not quite there yet.
    Heinssen RK; Insel TR
    Schizophr Bull; 2015 Jan; 41(1):28-9. PubMed ID: 25392518
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychoses during various ages].
    Lôo H
    Encephale; 2011 Sep; 37(4 Suppl 4):H1-2. PubMed ID: 22108179
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
    Ruhrmann S; Bechdolf A; Kühn KU; Wagner M; Schultze-Lutter F; Janssen B; Maurer K; Häfner H; Gaebel W; Möller HJ; Maier W; Klosterkötter J;
    Br J Psychiatry Suppl; 2007 Dec; 51():s88-95. PubMed ID: 18055944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.